ORGO
OrganogenesisDNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-20
Current thesis
Composite grade D from latest DB weights. Momentum 13.6 / Value 64.4
Posture
Defensive
Lead driver
Value
What changed
Value remains the lead driver in the composite, 7D delta -1.4.
What can break
Mixed signals. Wait for cleaner trend confirmation.
Momentum
14
Value
64
Sentiment
N/A
Setup hits (3d)
0 · Net Neutral
AI TargetsBase - · Bull - · Bear -
Data freshness
Prices
As of 2026-07-20
Fundamentals
As of 2026-07-20 • Vendor: Data Vendor v1
Scores
As of 2026-07-20 • Model: HYBRID_IC_RP
AI Memo
Unavailable: No memo yet
Investment thesisAs of 2026-07-20
Investment thesis
As of 2026-07-20
Supporting evidence
What
Grade D · Defensive
Confidence Medium · Net Neutral
Target $3.00
Why
Momentum14 · Δ7d -
Value64 · Δ7d -1.4
SentimentN/A · Δ7d -
So what
Weak posture (Net Neutral). Prioritize risk control and patience.
Lead driver: Value · See fundamentals
Momentum
14
40% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Value
64
60% active weight
Current posture
7d trendSoftening
Δ7d
-1.4
Δ21d
-0.7
Sentiment
N/A
Coverage pending
No current score
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade
Composite grade D. Momentum 13.6 / Value 64.4
Fundamentals (TTM)As of 2026-07-20
Fundamentals (TTM)
As of 2026-07-20
Market Cap
$338.41M
Beta
1.47
Shares Out
128.68M
P/E (TTM) · Derived
16.6
P/S (TTM)
1.20
P/FCF (TTM)
134.02
Rev YoY
-57.1%
EPS YoY
+157.0%
Gross Margin
+66.5%
Op Margin
-1.8%
Net Debt
-$12.19M
Current Ratio
3.53
As of 2026-07-20 • Updated nightlySource: Internal modelMethodology